☆ 4.5 Letter

Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation

ANNALS OF HEMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

ANNALS OF HEMATOLOGY
Volume 100, Issue 1, Pages 277-279

Publisher

SPRINGER
DOI: 10.1007/s00277-020-03974-y

Keywords

-

Categories

Hematology

Funding

  1. Projekt DEAL

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.